Hong Kong Life Sciences Stock News

MIXUE Group (SEHK:2097) FY 2025 earnings snapshot MIXUE Group (SEHK:2097) has reported FY 2025 results with second half revenue of C¥18.7b and basic EPS of C¥2.82, alongside trailing 12 month revenue of C¥33.6b and EPS of C¥7.83, giving investors a fresh look at how the business is scaling. The company has seen revenue move from C¥10.7b and EPS of C¥5.23 in the first half of 2024 to C¥14.9b and EPS of C¥7.23 in the first half of 2025, with trailing 12 month revenue stepping up from C¥24.8b...

Ping An Healthcare and Technology (SEHK:1833) has just posted its FY 2025 first half numbers, with revenue at C¥2.5b and basic EPS of C¥0.07, alongside net income of C¥134.2m that builds on its recent move into profitability. Over the recent reporting periods, revenue has shifted from C¥2.1b in 1H 2024 to C¥2.7b in 2H 2024 and C¥2.5b in 1H 2025, while basic EPS has moved from C¥0.05 in 1H 2024 to C¥0.02 in 2H 2024 and C¥0.07 in 1H 2025. This sets up a results story where investors will be...

Orient Overseas (International) (SEHK:316) shares were in focus after the company reported full year 2025 results showing lower sales and net income, alongside a proposed final dividend of US$0.42 per share payable in multiple currencies. See our latest analysis for Orient Overseas (International). The latest earnings update, which includes lower sales and net income alongside a proposed US$0.42 dividend, comes as the share price sits at HK$144.2 with a 90 day share price return of 16.1%. The...

What the latest results and board changes mean for Samsonite Group Samsonite Group (SEHK:1910) just packed several developments into one update, combining full year 2025 earnings, a proposed US$140 million dividend, a planned chairmanship handover and shareholder approval to prepare for a potential US dual listing. See our latest analysis for Samsonite Group. Those announcements landed after a tough stretch for the stock, with a 30 day share price return of 23.03% decline and a year to date...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has reported FY 2025 first half revenue of C¥950.4 million with a basic EPS loss of C¥0.64, while trailing twelve month revenue stands at C¥2.1 billion and basic EPS over that period is a loss of C¥3.20. The company has seen revenue move from C¥1.38 billion in 1H 2024 to C¥550.3 million in 2H 2024 and C¥950.4 million in 1H 2025, with EPS shifting from a profit of C¥1.41 in 1H 2024 to losses of C¥2.59 in 2H 2024 and C¥0.64 in 1H 2025...

This article examines whether KLN Logistics Group at HK$6.65 could be a potential bargain or a value trap, and walks through key signals to help you frame that question clearly. The stock has recently been under pressure, with returns of 1.8% over 7 days, 4.9% over 30 days, 7.9% year to date and 0.8% over the past year, alongside declines of 39.0% and 50.4% across 3 and 5 years respectively. Recent attention around KLN Logistics Group has focused less on short term headlines and more on how...

Celebrations may be in order for CK Hutchison Holdings Limited ( HKG:1 ) shareholders, with the analysts delivering a...

HM International Holdings Limited ( HKG:8416 ) just released a solid earnings report, and the stock displayed some...

Many investors are considering whether Pop Mart International Group shares still represent good value after a strong run, or whether the price has already moved ahead of the fundamentals. The stock last closed at HK$217.2, with returns of 0.8% over 7 days, an 11.1% decline over 30 days, 12.5% year to date and 71.9% over 1 year, along with a very large 3-year return. Recent attention has focused on how Pop Mart fits into consumer trends in collectibles and branded merchandise, with investors...

Even though Kingdee International Software Group Company Limited's ( HKG:268 ) recent earnings release was robust, the...

Last week, you might have seen that China Hongqiao Group Limited ( HKG:1378 ) released its yearly result to the market...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

The analysts covering Giant Biogene Holding Co., Ltd. ( HKG:2367 ) delivered a dose of negativity to shareholders...

Jinmao Property Services (SEHK:816) has released its FY 2025 results with first half revenue of C¥1.8b and basic EPS of C¥0.20, setting the tone for how the full year is shaping up. The company has seen revenue move from C¥1.49b in 1H 2024 to C¥1.47b in 2H 2024 and then to C¥1.78b in 1H 2025, while basic EPS has ranged from C¥0.19 in 1H 2024 to C¥0.22 in 2H 2024 and C¥0.20 in 1H 2025. This gives investors a clearer view of how the top line and EPS are tracking across recent periods. With...

China Resources Beer (Holdings) (SEHK:291) reported mixed FY 2025 results, with second half revenue of C¥14.0b and a basic EPS loss of C¥0.75, set against trailing 12 month revenue of C¥38.0b and EPS of C¥1.04. The company has seen half year revenue move from C¥14.9b in 2H 2024 to C¥23.9b in 1H 2025 and then C¥14.0b in 2H 2025, while basic EPS shifted from C¥0.01 in 2H 2024 to C¥1.78 in 1H 2025 before the recent loss. This sets up a story where investors are weighing compressed margins and a...

Fresh from its FY 2025 update, Lifestyle China Group (SEHK:2136) posted first half revenue of C¥617.8 million with a basic EPS loss of C¥0.002547, setting a cautious tone around profitability. The company has seen half yearly revenue move from C¥644.6 million and EPS of C¥0.028453 in 1H 2024 to C¥608.0 million and an EPS loss of C¥0.042181 in 2H 2024. Trailing 12 month figures show C¥1.21 billion of revenue and an EPS loss of C¥0.021, which keeps the focus firmly on earnings pressure. For you...

Spring Real Estate Investment Trust (SEHK:1426) has just posted its FY 2025 numbers, with first half revenue of C¥322.6 million and basic EPS of C¥0.024. This sets the tone for a year where income generation and payout capacity are firmly in focus for unitholders. Over the recent periods, revenue has moved from C¥361.5 million in 1H 2024 to C¥341.0 million in 2H 2024 and C¥322.6 million in 1H 2025. Basic EPS shifted from C¥0.029 in 1H 2024 to C¥0.061 in 2H 2024 and C¥0.024 in 1H 2025, giving...

Asia Financial Holdings (SEHK:662) has just posted its FY 2025 first half numbers, with revenue of HK$1,772.6 million, basic EPS of HK$0.46 and trailing 12 month EPS of HK$1.14 anchoring the latest set of results. The company has seen revenue move from HK$1,915.6 million in 1H FY 2024 to HK$1,848.8 million in 2H FY 2024 and HK$1,772.6 million in 1H FY 2025. Basic EPS tracked from HK$0.39 to HK$0.31 and now HK$0.46, setting the context for the reported 62.7% year over year earnings growth and...

Kerry Properties (SEHK:683) has released its FY 2025 figures with first half revenue at HK$8.1b and basic EPS of HK$0.42, setting the tone for how the rest of the year might look. Over the last three reported halves, revenue has moved from HK$5.0b in 1H 2024 to HK$14.5b in 2H 2024 and then to HK$8.1b in 1H 2025. Over the same periods, basic EPS has shifted from HK$0.54 to HK$0.01 and then to HK$0.42, giving investors a clearer view of how the topline and EPS pattern is evolving through the...

NagaCorp (SEHK:3918) has put up a solid set of FY 2025 numbers, with first half revenue of US$320.6 million and basic EPS of US$0.0336, set against reported earnings growth of 182.8% year over year and a five year compound growth rate of 45.7% per year. The company has seen revenue move from US$252.9 million in the second half of 2024 to US$320.6 million in the first half of 2025, while basic EPS shifted from US$0.0250 to US$0.0336 over the same periods. Investors will be weighing these...

Laopu Gold (SEHK:6181) has released its FY 2025 numbers with first half revenue of C¥12.4b and basic EPS of C¥13.38, set against trailing twelve month revenue of C¥27.3b and EPS of C¥28.35 that reflect earnings growth of 230.5% over the past year and an average of 66.3% per year over five years. Over recent periods the company has seen revenue move from C¥3.5b in 1H 2024 to C¥5.0b in 2H 2024 and then to C¥12.4b in 1H 2025, while basic EPS has shifted from C¥4.11 to C¥5.27 and then to C¥13.38,...

China Overseas Grand Oceans Group (SEHK:81) has put fresh numbers on the table for FY 2025, with first half revenue at C¥14.5b and basic EPS of C¥0.08. The trailing 12 month view shows revenue of C¥36.9b and EPS of C¥0.09 as the broader backdrop. Over the past three reported halves, revenue has moved from C¥21.9b in 1H 2024 to C¥24.0b in 2H 2024 and then to C¥14.5b in 1H 2025, with basic EPS shifting from C¥0.25 to C¥0.02 and then C¥0.08. This sets up a mixed picture that investors will weigh...

Essex Bio-Technology (SEHK:1061) has opened FY 2025 with first half revenue of HK$876.5 million and basic EPS of HK$0.29, setting the tone for how investors will read the latest set of numbers. The company has seen revenue move from HK$828.5 million in 1H 2024 to HK$858.2 million in 2H 2024 and then HK$876.5 million in 1H 2025, while basic EPS shifted from HK$0.28 to HK$0.26 and then HK$0.29 over the same periods. This gives a clear view of how the top and bottom lines are tracking into the...

WuXi XDC Cayman (SEHK:2268) has posted FY 2025 results that put the focus squarely on scale, with second half revenue of C¥3.2b and basic EPS of C¥0.60, underpinned by trailing twelve month revenue of C¥5.9b and EPS of C¥1.22. The company has seen revenue move from C¥2.4b in the second half of 2024 to C¥3.2b in the second half of 2025, with basic EPS over that period shifting from C¥0.48 to C¥0.60 as investors weigh a trailing net margin of 24.9% against a slightly lower level a year ago. See...